| Guidelines for the welfare and use of animals in cancer research P Workman, EO Aboagye, F Balkwill, A Balmain, G Bruder, DJ Chaplin, ... British journal of cancer 102 (11), 1555-1577, 2010 | 1447 | 2010 |
| Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas JL Teeling, RR French, MS Cragg, J van den Brakel, M Pluyter, H Huang, ... Blood 104 (6), 1793-1800, 2004 | 859 | 2004 |
| The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20 JL Teeling, WJM Mackus, LJJM Wiegman, JHN van den Brakel, SA Beers, ... The Journal of Immunology 177 (1), 362-371, 2006 | 821 | 2006 |
| Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts MS Cragg, SM Morgan, HTC Chan, BP Morgan, AV Filatov, ... Blood, The Journal of the American Society of Hematology 101 (3), 1045-1052, 2003 | 807 | 2003 |
| Immunostimulatory monoclonal antibodies for cancer therapy I Melero, S Hervas-Stubbs, M Glennie, DM Pardoll, L Chen Nature Reviews Cancer 7 (2), 95-106, 2007 | 763 | 2007 |
| Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents MS Cragg, MJ Glennie Blood 103 (7), 2738-2743, 2004 | 736 | 2004 |
| Mechanisms of killing by anti-CD20 monoclonal antibodies MJ Glennie, RR French, MS Cragg, RP Taylor Molecular immunology 44 (16), 3823-3837, 2007 | 661 | 2007 |
| CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help RR French, HT Chan, AL Tutt, MJ Glennie Nature medicine 5 (5), 548-553, 1999 | 520 | 1999 |
| The biology of CD20 and its potential as a target for mAb therapy MS Cragg, CA Walshe, AO Ivanov, MJ Glennie B cell trophic factors and B cell antagonism in autoimmune disease 8, 140-174, 2005 | 518 | 2005 |
| Clinical trials of antibody therapy MJ Glennie, PWM Johnson Immunology today 21 (8), 403-410, 2000 | 499 | 2000 |
| Agonistic CD40 antibodies and cancer therapy RH Vonderheide, MJ Glennie Clinical Cancer Research 19 (5), 1035-1043, 2013 | 489 | 2013 |
| Preparation and performance of bispecific F (ab'gamma) 2 antibody containing thioether-linked Fab'gamma fragments. MJ Glennie, HM McBride, AT Worth, GT Stevenson Journal of immunology (Baltimore, Md.: 1950) 139 (7), 2367-2375, 1987 | 464 | 1987 |
| Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection SA Beers, RR French, HTC Chan, SH Lim, TC Jarrett, RM Vidal, ... Blood, The Journal of the American Society of Hematology 115 (25), 5191-5201, 2010 | 401 | 2010 |
| The mechanisms of action of rituximab in the elimination of tumor cells P Johnson, M Glennie Seminars in oncology 30 (1), 3-8, 2003 | 352 | 2003 |
| Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies W Alduaij, A Ivanov, J Honeychurch, EJ Cheadle, S Potluri, SH Lim, ... Blood, The Journal of the American Society of Hematology 117 (17), 4519-4529, 2011 | 351 | 2011 |
| Anti-CD20 monoclonal antibodies: historical and future perspectives SH Lim, SA Beers, RR French, PWM Johnson, MJ Glennie, MS Cragg haematologica 95 (1), 135, 2010 | 333 | 2010 |
| Trispecific F (ab') 3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells. A Tutt, GT Stevenson, MJ Glennie Journal of immunology (Baltimore, Md.: 1950) 147 (1), 60-69, 1991 | 305 | 1991 |
| Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy SH Lim, AT Vaughan, M Ashton-Key, EL Williams, SV Dixon, HTC Chan, ... Blood, The Journal of the American Society of Hematology 118 (9), 2530-2540, 2011 | 292 | 2011 |
| CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts HTC Chan, D Hughes, RR French, AL Tutt, CA Walshe, JL Teeling, ... Cancer research 63 (17), 5480-5489, 2003 | 288 | 2003 |
| CD20 as a target for therapeutic type I and II monoclonal antibodies SA Beers, CHT Chan, RR French, MS Cragg, MJ Glennie Seminars in hematology 47 (2), 107-114, 2010 | 279 | 2010 |
